Flow dynamics, binding and detachment of spherical carriers targeted to ICAM-1 on endothelial cells.

PubWeight™: 1.32‹?› | Rank: Top 10%

🔗 View Article (PMC 2766098)

Published in Biorheology on January 01, 2009

Authors

Andres J Calderon1, Vladimir Muzykantov, Silvia Muro, David M Eckmann

Author Affiliations

1: Department of Anesthesiology and Critical Care, University of Pennsylvania Medical School, Philadelphia, PA, USA.

Articles citing this

Nanoparticle Brownian motion and hydrodynamic interactions in the presence of flow fields. Phys Fluids (1994) (2011) 1.60

Computational model for nanocarrier binding to endothelium validated using in vivo, in vitro, and atomic force microscopy experiments. Proc Natl Acad Sci U S A (2010) 1.53

Optimizing endothelial targeting by modulating the antibody density and particle concentration of anti-ICAM coated carriers. J Control Release (2010) 1.27

Multiscale Modeling of Functionalized Nanocarriers in Targeted Drug Delivery. Curr Nanosci (2011) 1.04

Acute and chronic shear stress differently regulate endothelial internalization of nanocarriers targeted to platelet-endothelial cell adhesion molecule-1. ACS Nano (2012) 1.02

Dynamic factors controlling targeting nanocarriers to vascular endothelium. Curr Drug Metab (2012) 1.02

Effect of flow on endothelial endocytosis of nanocarriers targeted to ICAM-1. J Control Release (2011) 1.01

Dynamic factors controlling carrier anchoring on vascular cells. IUBMB Life (2011) 1.00

A hybrid formalism combining fluctuating hydrodynamics and generalized Langevin dynamics for the simulation of nanoparticle thermal motion in an incompressible fluid medium. Mol Phys (2012) 0.99

Temporal Multiscale Approach for Nanocarrier Motion with Simultaneous Adhesion and Hydrodynamic Interactions in Targeted Drug Delivery. J Comput Phys (2013) 0.97

Nanocarrier Hydrodynamics and Binding in Targeted Drug Delivery: Challenges in Numerical Modeling and Experimental Validation. J Nanotechnol Eng Med (2013) 0.95

Reduction of nanoparticle avidity enhances the selectivity of vascular targeting and PET detection of pulmonary inflammation. ACS Nano (2013) 0.94

Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm. ACS Nano (2014) 0.92

Targeting of ICAM-1 on vascular endothelium under static and shear stress conditions using a liposomal Gd-based MRI contrast agent. J Nanobiotechnology (2012) 0.87

Vascular deposition patterns for nanoparticles in an inflamed patient-specific arterial tree. Biomech Model Mechanobiol (2013) 0.83

Shear forces from flow are responsible for a distinct statistical signature of adherent microbubbles in large vessels. Mol Imaging (2013) 0.82

Nanocarriers for vascular delivery of anti-inflammatory agents. Annu Rev Pharmacol Toxicol (2014) 0.81

Biophysically inspired model for functionalized nanocarrier adhesion to cell surface: roles of protein expression and mechanical factors. R Soc Open Sci (2016) 0.80

Chitosan-Alginate Microcapsules Provide Gastric Protection and Intestinal Release of ICAM-1-Targeting Nanocarriers, Enabling GI Targeting In Vivo. Adv Funct Mater (2016) 0.80

Collaborative Enhancement of Endothelial Targeting of Nanocarriers by Modulating Platelet-Endothelial Cell Adhesion Molecule-1/CD31 Epitope Engagement. ACS Nano (2015) 0.79

Dynamics of receptor-mediated nanoparticle internalization into endothelial cells. PLoS One (2015) 0.79

Flow shear stress differentially regulates endothelial uptake of nanocarriers targeted to distinct epitopes of PECAM-1. J Control Release (2015) 0.79

Altered Clathrin-Independent Endocytosis in Type A Niemann-Pick Disease Cells and Rescue by ICAM-1-Targeted Enzyme Delivery. Mol Pharm (2015) 0.78

A Comparative Study on the Alterations of Endocytic Pathways in Multiple Lysosomal Storage Disorders. Mol Pharm (2016) 0.78

Non-affinity factors modulating vascular targeting of nano- and microcarriers. Adv Drug Deliv Rev (2015) 0.78

Characterization of nanoparticle delivery in microcirculation using a microfluidic device. Microvasc Res (2014) 0.78

Distinct subcellular trafficking resulting from monomeric vs multimeric targeting to endothelial ICAM-1: implications for drug delivery. Mol Pharm (2014) 0.76

Nanocarrier-Cell Surface Adhesive and Hydrodynamic Interactions: Ligand-Receptor Bond Sensitivity Study. J Nanotechnol Eng Med (2013) 0.76

Biomimetic channel modeling local vascular dynamics of pro-inflammatory endothelial changes. Biomicrofluidics (2016) 0.76

The Future of Nanoparticle-Directed Venous Therapy. Semin Intervent Radiol (2017) 0.75

Effect of Glycocalyx on Drug Delivery Carriers Targeted to Endothelial Cells. Int J Transp Phenom (2011) 0.75

Vascular-targeted nanocarriers: design considerations and strategies for successful treatment of atherosclerosis and other vascular diseases. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2016) 0.75

Targeting cell adhesion molecules with nanoparticles using in vivo and flow-based in vitro models of atherosclerosis. Exp Biol Med (Maywood) (2017) 0.75

Articles cited by this

Models for the specific adhesion of cells to cells. Science (1978) 28.03

Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell (1987) 9.41

Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood (1998) 7.70

Direct observation of catch bonds involving cell-adhesion molecules. Nature (2003) 6.30

Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science (1991) 5.76

Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nat Biotechnol (2007) 3.54

Intravascular delivery of particulate systems: does geometry really matter? Pharm Res (2008) 3.13

The adhesive strength of non-spherical particles mediated by specific interactions. Biomaterials (2006) 2.71

Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. Mol Ther (2008) 2.69

Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. Circulation (1998) 2.57

Activation of Rac1 by shear stress in endothelial cells mediates both cytoskeletal reorganization and effects on gene expression. EMBO J (2002) 2.46

A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1. J Cell Sci (2003) 2.34

Mechanism of endothelial cell shape change and cytoskeletal remodeling in response to fluid shear stress. J Cell Sci (1996) 2.18

Rolling and transient tethering of leukocytes on antibodies reveal specializations of selectins. Proc Natl Acad Sci U S A (1997) 2.01

Endothelial targeting of high-affinity multivalent polymer nanocarriers directed to intercellular adhesion molecule 1. J Pharmacol Exp Ther (2006) 1.93

Drug targeting. Eur J Pharm Sci (2000) 1.91

Ultrasound imaging of acute cardiac transplant rejection with microbubbles targeted to intercellular adhesion molecule-1. Circulation (2003) 1.83

Control of intracellular trafficking of ICAM-1-targeted nanocarriers by endothelial Na+/H+ exchanger proteins. Am J Physiol Lung Cell Mol Physiol (2005) 1.81

Determining force dependence of two-dimensional receptor-ligand binding affinity by centrifugation. Biophys J (1998) 1.78

Tumor necrosis factor alpha regulates in vivo intrapulmonary expression of ICAM-1. Am J Pathol (1993) 1.74

Biomedical aspects of targeted delivery of drugs to pulmonary endothelium. Expert Opin Drug Deliv (2005) 1.61

Modulating targeted adhesion of an ultrasound contrast agent to dysfunctional endothelium. Ann Biomed Eng (2002) 1.59

ICAM-1 recycling in endothelial cells: a novel pathway for sustained intracellular delivery and prolonged effects of drugs. Blood (2004) 1.58

Vascular endothelium, hemodynamic forces, and atherogenesis. Am J Pathol (1999) 1.57

Slow intracellular trafficking of catalase nanoparticles targeted to ICAM-1 protects endothelial cells from oxidative stress. Am J Physiol Cell Physiol (2003) 1.54

Advanced drug delivery systems that target the vascular endothelium. Mol Interv (2006) 1.54

Targeting of antioxidant and anti-thrombotic drugs to endothelial cell adhesion molecules. Curr Pharm Des (2005) 1.53

Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo. Proc Natl Acad Sci U S A (2003) 1.48

Neutrophil traction stresses are concentrated in the uropod during migration. Biophys J (2007) 1.45

Interplay between rolling and firm adhesion elucidated with a cell-free system engineered with two distinct receptor-ligand pairs. Biophys J (2003) 1.44

Targeting ICAM-1/LFA-1 interaction for controlling autoimmune diseases: designing peptide and small molecule inhibitors. Peptides (2003) 1.35

Fluid shear stress differentially modulates expression of genes encoding basic fibroblast growth factor and platelet-derived growth factor B chain in vascular endothelium. J Clin Invest (1993) 1.33

Receptor-mediated cell attachment and detachment kinetics. II. Experimental model studies with the radial-flow detachment assay. Biophys J (1990) 1.32

PLGA nanoparticle--peptide conjugate effectively targets intercellular cell-adhesion molecule-1. Bioconjug Chem (2007) 1.31

Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cells. Blood (2002) 1.30

Lysosomal enzyme delivery by ICAM-1-targeted nanocarriers bypassing glycosylation- and clathrin-dependent endocytosis. Mol Ther (2005) 1.29

Delivery of acid sphingomyelinase in normal and niemann-pick disease mice using intercellular adhesion molecule-1-targeted polymer nanocarriers. J Pharmacol Exp Ther (2008) 1.28

ICAM-directed vascular immunotargeting of antithrombotic agents to the endothelial luminal surface. Blood (2003) 1.28

Lung uptake of antibodies to endothelial antigens: key determinants of vascular immunotargeting. Am J Physiol Lung Cell Mol Physiol (2001) 1.18

Adhesion molecules: a new target for immunoliposome-mediated drug delivery. FEBS Lett (1995) 1.16

Polymeric carriers: role of geometry in drug delivery. Expert Opin Drug Deliv (2008) 1.14

I-domain of lymphocyte function-associated antigen-1 mediates rolling of polystyrene particles on ICAM-1 under flow. Biophys J (2005) 1.10

Interplay between shear stress and adhesion on neutrophil locomotion. Biophys J (2006) 1.08

The Role of Glycocalyx in Nanocarrier-Cell Adhesion Investigated Using a Thermodynamic Model and Monte Carlo Simulations. J Phys Chem C Nanomater Interfaces (2007) 1.05

Flow-related responses of intracellular inositol phosphate levels in cultured aortic endothelial cells. Circ Res (1993) 1.03

Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes. Biomaterials (2002) 1.01

Ligand coated nanosphere adhesion to E- and P-selectin under static and flow conditions. Ann Biomed Eng (2001) 1.00

The role of flexible tethers in multiple ligand-receptor bond formation between curved surfaces. Biophys J (2006) 0.99

Targeting microparticles to select tissue via radiation-induced upregulation of endothelial cell adhesion molecules. Pharm Res (2002) 0.97

Microparticle adhesive dynamics and rolling mediated by selectin-specific antibodies under flow. Biotechnol Bioeng (2007) 0.93

Artificial polymeric cells for targeted drug delivery. J Control Release (2003) 0.92

Adhesion from tethered ligand-receptor bonds with microsecond lifetimes. Langmuir (2007) 0.92

Tumor vasculature directed drug targeting: applying new technologies and knowledge to the development of clinically relevant therapies. Pharm Res (2002) 0.90

Immunoliposomes directed toward VCAM-1 interact specifically with activated endothelial cells--a potential tool for specific drug delivery. Pharm Res (2005) 0.88

A peptide derived from LFA-1 protein that modulates T-cell adhesion binds to soluble ICAM-1 protein. J Biomol Struct Dyn (2003) 0.84

Early detection of bleomycin-induced lung injury in rat using indium-111-labeled antibody directed against intercellular adhesion molecule-1. J Nucl Med (1998) 0.84

In vitro and in situ intercellular adhesion molecule-1 (ICAM-1) expression by endothelial cells lining a polyester fabric. Biomaterials (1999) 0.80

Articles by these authors

Oxygen microscopy by two-photon-excited phosphorescence. Chemphyschem (2008) 2.17

1-Cys peroxiredoxin overexpression protects cells against phospholipid peroxidation-mediated membrane damage. Proc Natl Acad Sci U S A (2002) 1.65

Intercellular adhesion molecule 1 engagement modulates sphingomyelinase and ceramide, supporting uptake of drug carriers by the vascular endothelium. Arterioscler Thromb Vasc Biol (2012) 1.55

Advanced drug delivery systems that target the vascular endothelium. Mol Interv (2006) 1.54

Computational model for nanocarrier binding to endothelium validated using in vivo, in vitro, and atomic force microscopy experiments. Proc Natl Acad Sci U S A (2010) 1.53

Immunotargeting of catalase to the pulmonary endothelium alleviates oxidative stress and reduces acute lung transplantation injury. Nat Biotechnol (2003) 1.46

Embolism bubble adhesion force in excised perfused microvessels. Anesthesiology (2003) 1.40

Pro-thrombotic state induced by post-translational modification of fibrinogen by reactive nitrogen species. J Biol Chem (2003) 1.36

In vivo imaging of 64Cu-labeled polymer nanoparticles targeted to the lung endothelium. J Nucl Med (2007) 1.30

Delivery of acid sphingomyelinase in normal and niemann-pick disease mice using intercellular adhesion molecule-1-targeted polymer nanocarriers. J Pharmacol Exp Ther (2008) 1.28

ICAM-directed vascular immunotargeting of antithrombotic agents to the endothelial luminal surface. Blood (2003) 1.28

Optimizing endothelial targeting by modulating the antibody density and particle concentration of anti-ICAM coated carriers. J Control Release (2010) 1.27

Endothelial endocytic pathways: gates for vascular drug delivery. Curr Vasc Pharmacol (2004) 1.25

The effect of CD47 modified polymer surfaces on inflammatory cell attachment and activation. Biomaterials (2011) 1.17

Enhanced endothelial delivery and biochemical effects of α-galactosidase by ICAM-1-targeted nanocarriers for Fabry disease. J Control Release (2010) 1.16

RhoA activation and actin reorganization involved in endothelial CAM-mediated endocytosis of anti-PECAM carriers: critical role for tyrosine 686 in the cytoplasmic tail of PECAM-1. Blood (2008) 1.13

Multivalent binding of nanocarrier to endothelial cells under shear flow. Biophys J (2011) 1.13

High throughput modular chambers for rapid evaluation of anesthetic sensitivity. BMC Anesthesiol (2006) 1.10

Targeted delivery of therapeutics to endothelium. Cell Tissue Res (2008) 1.10

Dissociation between alveolar transmigration of neutrophils and lung injury in hyperoxia. Am J Physiol Lung Cell Mol Physiol (2006) 1.08

Nanocarriers for vascular delivery of antioxidants. Nanomedicine (Lond) (2011) 1.06

Surfactant reduction in embolism bubble adhesion and endothelial damage. Anesthesiology (2004) 1.06

Differential intra-endothelial delivery of polymer nanocarriers targeted to distinct PECAM-1 epitopes. J Control Release (2008) 1.06

Numerical study of wall effects on buoyant gas-bubble rise in a liquid-filled finite cylinder. Phys Rev E Stat Nonlin Soft Matter Phys (2007) 1.05

Multiscale Modeling of Functionalized Nanocarriers in Targeted Drug Delivery. Curr Nanosci (2011) 1.04

Air bubble contact with endothelial cells causes a calcium-independent loss in mitochondrial membrane potential. PLoS One (2012) 1.03

Endothelial targeting of antibody-decorated polymeric filomicelles. ACS Nano (2011) 1.03

Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells. ACS Nano (2013) 1.02

Acute and chronic shear stress differently regulate endothelial internalization of nanocarriers targeted to platelet-endothelial cell adhesion molecule-1. ACS Nano (2012) 1.02

Dynamic factors controlling targeting nanocarriers to vascular endothelium. Curr Drug Metab (2012) 1.02

Effect of flow on endothelial endocytosis of nanocarriers targeted to ICAM-1. J Control Release (2011) 1.01

Dynamic factors controlling carrier anchoring on vascular cells. IUBMB Life (2011) 1.00

In vitro surfactant mitigation of gas bubble contact-induced endothelial cell death. Undersea Hyperb Med (2011) 0.98

Mechanotransductional basis of endothelial cell response to intravascular bubbles. Integr Biol (Camb) (2011) 0.98

Enhanced delivery of α-glucosidase for Pompe disease by ICAM-1-targeted nanocarriers: comparative performance of a strategy for three distinct lysosomal storage disorders. Nanomedicine (2011) 0.97

Transport of nanocarriers across gastrointestinal epithelial cells by a new transcellular route induced by targeting ICAM-1. J Control Release (2012) 0.97

Finite-sized gas bubble motion in a blood vessel: non-Newtonian effects. Phys Rev E Stat Nonlin Soft Matter Phys (2008) 0.96

Model predictions of gas embolism growth and reabsorption during xenon anesthesia. Anesthesiology (2003) 0.96

Air bubble contact with endothelial cells in vitro induces calcium influx and IP3-dependent release of calcium stores. Am J Physiol Cell Physiol (2011) 0.96

Correlating macrophage morphology and cytokine production resulting from biomaterial contact. J Biomed Mater Res A (2012) 0.96

A quantitative and selective chromatography method for determining coverages of multiple proteins on surfaces. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 0.96

Nanocarrier Hydrodynamics and Binding in Targeted Drug Delivery: Challenges in Numerical Modeling and Experimental Validation. J Nanotechnol Eng Med (2013) 0.95

Reduction of nanoparticle avidity enhances the selectivity of vascular targeting and PET detection of pulmonary inflammation. ACS Nano (2013) 0.94

Comparative binding, endocytosis, and biodistribution of antibodies and antibody-coated carriers for targeted delivery of lysosomal enzymes to ICAM-1 versus transferrin receptor. J Inherit Metab Dis (2012) 0.93

Imaging macromolecular interactions at an interface. Langmuir (2010) 0.92

Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm. ACS Nano (2014) 0.92

Symmetric pH-dependent swelling and antibacterial properties of chitosan brushes. Langmuir (2011) 0.91

Human macrophage adhesion on polysaccharide patterned surfaces. Soft Matter (2011) 0.89

Endothelial targeting of polymeric nanoparticles stably labeled with the PET imaging radioisotope iodine-124. Biomaterials (2012) 0.89

Accelerated arteriolar gas embolism reabsorption by an exogenous surfactant. Anesthesiology (2002) 0.89

Human plasma protein adsorption onto dextranized surfaces: a two-dimensional electrophoresis and mass spectrometry study. Colloids Surf B Biointerfaces (2011) 0.88

Antibacterial Biomimetic Hybrid Films. Soft Matter (2013) 0.87

Dextran functionalized surfaces via reductive amination: morphology, wetting, and adhesion. Biomacromolecules (2006) 0.87

Specific binding, uptake, and transport of ICAM-1-targeted nanocarriers across endothelial and subendothelial cell components of the blood-brain barrier. Pharm Res (2014) 0.87

A facile route to synthesize nanogels doped with silver nanoparticles. J Nanopart Res (2012) 0.86

Creating biomimetic polymeric surfaces by photochemical attachment and patterning of dextran. Langmuir (2010) 0.86

Dose- and time-dependent liquid sclerosant effects on endothelial cell death. Dermatol Surg (2006) 0.86

Cellular Uptake and Intracellular Cargo Release From Dextran Based Nanogel Drug Carriers. J Nanotechnol Eng Med (2013) 0.85

Bubble motion through a generalized power-law fluid flowing in a vertical tube. Ann N Y Acad Sci (2009) 0.85

Targeted delivery of antibody-based therapeutic and imaging agents to CNS tumors: crossing the blood-brain barrier divide. Expert Opin Drug Deliv (2013) 0.85

Competitive protein adsorption on polysaccharide and hyaluronate modified surfaces. Biofouling (2011) 0.85

Open challenges in magnetic drug targeting. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2014) 0.84

In vivo performance of polymer nanocarriers dually-targeted to epitopes of the same or different receptors. Biomaterials (2013) 0.83

Biodistribution and endocytosis of ICAM-1-targeting antibodies versus nanocarriers in the gastrointestinal tract in mice. Int J Nanomedicine (2012) 0.83

Gold nanorod linking to control plasmonic properties in solution and polymer nanocomposites. Langmuir (2014) 0.83

Reversible Swelling of Chitosan and Quaternary Ammonium Modified Chitosan Brush Layers: Effect of pH and Counter Anion Size and Functionality. J Mater Chem (2012) 0.82

Biological functionalization of drug delivery carriers to bypass size restrictions of receptor-mediated endocytosis independently from receptor targeting. ACS Nano (2013) 0.82

Protein assembly at the air-water interface studied by fluorescence microscopy. Langmuir (2011) 0.82

Models and methods to evaluate transport of drug delivery systems across cellular barriers. J Vis Exp (2013) 0.81

Photo-activated porphyrin in combination with antibiotics: therapies against Staphylococci. J Photochem Photobiol B (2013) 0.81

Flow-dependent channel formation in clots by an erythrocyte-bound fibrinolytic agent. Blood (2011) 0.80

Hemocompatibility and biocompatibility of antibacterial biomimetic hybrid films. Toxicol Appl Pharmacol (2013) 0.80

Collaborative Enhancement of Endothelial Targeting of Nanocarriers by Modulating Platelet-Endothelial Cell Adhesion Molecule-1/CD31 Epitope Engagement. ACS Nano (2015) 0.79

Clathrin-mediated endocytosis is impaired in type A-B Niemann-Pick disease model cells and can be restored by ICAM-1-mediated enzyme replacement. Mol Pharm (2014) 0.79

A fibrinogen-derived peptide provides intercellular adhesion molecule-1-specific targeting and intraendothelial transport of polymer nanocarriers in human cell cultures and mice. J Pharmacol Exp Ther (2011) 0.78

Targeting, endocytosis, and lysosomal delivery of active enzymes to model human neurons by ICAM-1-targeted nanocarriers. Pharm Res (2014) 0.77

Hydrodynamic interactions of deformable polymeric nanocarriers and the effect of crosslinking. Soft Matter (2015) 0.77

Targeting to endothelial cells augments the protective effect of novel dual bioactive antioxidant/anti-inflammatory nanoparticles. Mol Pharm (2014) 0.77

Endothelial nanomedicine for the treatment of pulmonary disease. Expert Opin Drug Deliv (2014) 0.77

A guest molecule-host cavity fitting algorithm to mine PDB for small molecule targets. Biochim Biophys Acta (2006) 0.77

Distinct subcellular trafficking resulting from monomeric vs multimeric targeting to endothelial ICAM-1: implications for drug delivery. Mol Pharm (2014) 0.76

Numerical modeling of the transport to an intravascular bubble in a tube with a soluble/insoluble surfactant. Ann N Y Acad Sci (2006) 0.76

Effect of thiol pendant conjugates on plasmid DNA binding, release, and stability of polymeric delivery vectors. Biomacromolecules (2012) 0.76

Computational simulation of hematocrit effects on arterial gas embolism dynamics. Aviat Space Environ Med (2012) 0.76

Effect of Glycocalyx on Drug Delivery Carriers Targeted to Endothelial Cells. Int J Transp Phenom (2011) 0.75

Targeted release of tobramycin from a pH-responsive grafted bilayer challenged with S. aureus. Biomacromolecules (2015) 0.75

Intravital microscopy methods in microvascular blood flow and tissue oxygenation. Undersea Hyperb Med (2012) 0.75

Air bubble growth in water. Anesthesiology (2006) 0.75

Enhancing biodistribution of therapeutic enzymes in vivo by modulating surface coating and concentration of ICAM-1-targeted nanocarriers. J Biomed Nanotechnol (2014) 0.75

Regarding "Stroke after varicose vein foam injection sclerotherapy". J Vasc Surg (2006) 0.75

Using 3-D dense packing models to predict surface tension change due to protein adsorption. Int J Transp Phenom (2011) 0.75

Pefluorocarbon inhibition of bubble induced Ca2+ transients in an in vitro model of vascular gas embolism. Exp Biol Med (Maywood) (2013) 0.75